Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AUY922 in metastatic pancreatic cancer
NCT01484860Phase 2Terminated
- Sponsor
- University Health Network
- Start
- Jan 2012
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Luminespib in pancreatic adenocarcinoma (PDAC), sponsored by University Health Network. Started Jan 2012; status: terminated.
02
Drugs
Luminespib
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT01484860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01484860.